Solu-medrol and Ureteric anastomosis complication - a phase IV clinical study of FDA data

Summary:

Ureteric anastomosis complication is reported only by a few people who take Solu-Medrol.

The phase IV clinical study analyzes which people take Solu-medrol and have Ureteric anastomosis complication. It is created by eHealthMe based on reports of 30,159 people who have side effects while taking Solu-medrol from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Aug, 03, 2022

30,159 people reported to have side effects when taking Solu-medrol.
Among them, 5 people (0.02%) have Ureteric anastomosis complication.


What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 30,302 Solu-medrol users for its effectiveness, alternative drugs and more.

What is Ureteric anastomosis complication?

Ureteric anastomosis complication is found to be associated with 43 drugs and 20 conditions by eHealthMe.

Number of Solu-medrol and Ureteric anastomosis complication reports submitted per year:

Could Solu-medrol cause Ureteric anastomosis complication?

Time on Solu-medrol when people have Ureteric anastomosis complication *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Ureteric anastomosis complication when taking Solu-medrol *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Ureteric anastomosis complication when taking Solu-medrol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 75 %
  • 40-49: 25 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Solu-medrol *:

  1. Vancomycin Hydrochloride: 5 people, 100.00%
  2. Simulect: 5 people, 100.00%
  3. Sandimmune: 5 people, 100.00%
  4. Neoral: 5 people, 100.00%
  5. Medrol: 5 people, 100.00%
  6. Cellcept: 5 people, 100.00%
  7. Prograf: 4 people, 80.00%
  8. Orthoclone Okt3: 3 people, 60.00%

Common side effects people have besides Ureteric anastomosis complication *:

  1. Viral Infection: 5 people, 100.00%
  2. Urinary Tract Inflammation: 5 people, 100.00%
  3. Staphylococcal Infection (an infection with staphylococcus bacteria): 5 people, 100.00%
  4. Respiratory Distress (difficulty in breathing): 5 people, 100.00%
  5. Immunodeficiency: 5 people, 100.00%
  6. Histiocytosis Haematophagic: 5 people, 100.00%
  7. Gastroenteritis Staphylococcal (inflammation of stomach and intestine caused by staphylococcal infection): 5 people, 100.00%
  8. Fever: 5 people, 100.00%
  9. Diarrhea: 5 people, 100.00%
  10. Cytomegalovirus Antigen Positive: 5 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-medrol and have Ureteric anastomosis complication?

Check whether Ureteric anastomosis complication is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Solu-medrol:

Ureteric anastomosis complication treatments and more:

COVID vaccines that are related to Ureteric anastomosis complication:

How severe was Ureteric anastomosis complication and when was it recovered:

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

All the drugs that are associated with Ureteric anastomosis complication:

All the conditions that are associated with Ureteric anastomosis complication:

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Solu-medrol) and Solu-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: